Together, let us build a healthier future
Shen Clinical Services work hand in hand with pharmaceutical companies, offering end-to-end solutions that encompass research and development, clinical trials, regulatory compliance, manufacturing, and supply chain management.
Shen Clinical Services stands at the forefront of clinical research as a trusted Contract Research Organization (CRO) with distinguished expertise in pharmacovigilance. Our dedication to advancing drug development while prioritizing patient safety sets us apart. We uphold the highest ethical standards, ensuring that our research and pharmacovigilance services adhere to regulatory guidelines and Good Clinical Practice (GCP). Our global reach allows us to collaborate with pharmaceutical, biotech, and academic institutions to accelerate the journey from drug discovery to market. When you choose Shen Clinical Services, you’re choosing a partner committed to excellence and driving progress in healthcare.
Our reliability extends beyond project execution
Shen Clinical Services stands at the forefront of clinical research as a trusted Contract Research Organization (CRO) with distinguished expertise in pharmacovigilance. Our dedication to advancing drug development while prioritizing patient safety sets us apart. We uphold the highest ethical standards, ensuring that our research and pharmacovigilance services adhere to regulatory guidelines and Good Clinical Practice (GCP). Our global reach allows us to collaborate with pharmaceutical, biotech, and academic institutions to accelerate the journey from drug discovery to market. When you choose Shen Clinical Services, you’re choosing a partner committed to excellence and driving progress in healthcare.
Excellence is not a destination; it is a continuous journey
Excellence is not a destination that we reach and then rest upon our laurels. It is a mindset, a way of being that drives us to do better each day. It is a commitment to lifelong learning, innovation, and delivering exceptional results.
Shen believe that excellence is also a collaborative endeavour. We actively seek partnerships and collaborations with leading experts, research institutions, and industry pioneers.
Our team embraces a culture of continuous learning and improvement. We encourage our staff to stay at the forefront of industry advancements, to seek new knowledge, and to embrace emerging technologies and methodologies.
Quality is at the core of our operations
Shen Clinical Services is committed to complying with Good Clinical Practice (GCP) guidelines and relevant regulatory frameworks, we guarantee the integrity and reliability of the data we collect, protect the rights and safety of study participants, and maintain the highest ethical standards throughout the clinical trial process.
Continuous monitoring, auditing, and quality control are integral to our culture to ensure that our operations are aligned with our quality objectives.
With our culture of quality as the cornerstone of our organization, we are confident in our ability to navigate the complexities of clinical research, meet the evolving needs of our clients, and contribute to the development of life-changing therapies.
Our name as “Shen”
Chinese Medicine: In Traditional Chinese Medicine (TCM), “Shen” represents the concept of vitality or the overall state of mental and emotional well-being. It is closely related to the heart and is believed to influence a person’s mental clarity, emotional balance, and overall vitality.
Egyptian Mythology: In Egyptian mythology, “Shen” is a hieroglyphic symbol in the shape of a looped circle. It represents eternity, infinity, or protection and is often depicted as a decorative motif in ancient Egyptian art and architecture.
Chinese Concept: In Chinese philosophy and medicine, “Shen” refers to the spiritual aspect or the divine presence within an individual. It encompasses the mind, consciousness, and spiritual essence.
Hence, from the very beginning we have maintained a strong emphasis on:
- Scientific Excellence
- Technical Expertise
- High Value System
- Uncompromising Ethics
- Constant Innovation and
- Advancement of Medical Science
Our Team
Ashok Srivastava is the Chief Medical Officer of Trans Atlantic Therapeutics Oncology, He was the Chief Medical Officer of CareBeyond – A Radiation Therapy Cancer Center, New Jersey, USA. He has more than 15 years of experience in drug development, medical affairs, and commercialization of cancer drugs including radiopharmaceutical and supportive care; Phase I – 4, and marketing commercialization of Hematology, Oncology, and radiopharmaceutical drugs in the USA, EU, and Japan. He is the leader in Cancer Drug Development Worldwide large and complex Phase 3 Clinical Trials in many countries. He contributed to 21-INDs and 7-NDAs of Cancer Drugs, the acquisition /merger of a company and drug for more than $300 million. He received his clinical, and medical training & worked at renowned medical centers and pharmaceutical institutions worldwide; Walter Reed Army Institute of Research and Medical Center, Daiichi, Sumitomo, Pharmacia, Pfizer, Eisai Oncology, and Spectrum Pharmaceuticals. He received his Clinical, Medical & Business educations from All India Institute of Medical Sciences, New Delhi, India; the Academy of Medical Sciences, Czechoslovakia; the School of Medicine Nagasaki University, Japan, and Pharmaceutical Business at Rutgers University Business Management, New Jersey, USA. He played a key role in a dramatic expansion of oncology drug–developed cancer drugs- Sutent (Sunitinib), Evoxac (Cevimeline HCl), and liposomal doxorubicin (Myocet) in combination with Herceptin & Paclitaxel for HER2 positive metastatic breast cancer patients and latuda (Lurasidone) for schizophrenia He is one of the inventors of Japanese encephalitis vaccine (IXIARO). He has published more than 85 papers in National and International Journals, more than 120 abstracts, 3 book chapters, and 2 patents. He is the recipient of numerous National & International prestigious medical awards and recognitions from the United Nations, Ministry of Health, Japan, Department of Army, Walter Reed Army Medical Center, and Walter Reed Army Institute of Research, Washington DC, USA. He served as a medical advisor to Poniard Pharmaceutical for small-cell lung cancer in the USA, EU, and India. Srivastava is a member of numerous prestigious organizations; America’s Top Oncologist of the years 2007, 2008, and 2011, Breast Cancer Foundation, Indian Society of Oncology, American Society of Clinical Oncology, American Society for Therapeutic Radiology & Oncology, American Association of Cancer Research, and International Society of Lung Cancer. Dr. Srivastava is a strategic medical advisor and Board Member to several pharma in the USA for clinical, regulatory, and supervises cancer drug development. Recently Dr. Srivastava was awarded membership in Japan External Trade Organization, USA. Dr. Srivastava is a Leader in Drug Safety, pharmacovigilance of Oncology, hematology, and immuno-oncology and built global drug safety and pharmacovigilance companies in the USA, and India. Dr. Srivastava was invited as an honorable speaker at the drug safety & Pharmacovigilance congress in London, UK, China, India, and Washington, DC, USA in Jan 2012, 2013, and 2017. Dr. Srivastava brought 2 cancer drugs & a vaccine to a global market for approx 3 – 3.5 billion $ in global sales. He serves on the board of directors for oncology virtual pharma companies in the USA. He is on the Board of advisors to Calidi Biotherapeutics.
Dr. Ashok Srivastava, MD, Ph.D., MBA
Dr. Mahendra Sharma possesses an exceptional and lucrative profile as a distinguished expert in Ayurvedic medicine and pediatrics. He holds a B.A.M.S degree from M.M.M Govt. Ayurvedic College, Udaipur, and an M.D. in Pediatrics (Ayurveda) from the prestigious National Institute of Ayurveda, Jaipur.
With an impressive 19-year teaching career, Dr. Sharma has earned recognition as a leading authority in Ayurvedic medicine. He has held the position of Assistant Professor at esteemed Ayurvedic colleges in Punjab and Haryana, imparting his extensive knowledge to the next generation of practitioners.
Currently, Dr. Sharma serves as an Associate Professor in the Ayurvedic Pediatrics Department at M.S.M Institute of Ayurveda, further solidifying his status as an expert in the field. Additionally, he holds the role of Director of Youth Welfare at B.P.S Women University in Khanpur Kalan (Sonipat), where he continues to inspire and guide the youth while promoting the principles of Ayurveda.
Dr. Mahendra Sharma’s illustrious career reflects his dedication to being an eminent expert in Ayurvedic medicine and pediatrics, contributing significantly to research, education, and clinical practice. His profile is not only lucrative but also a testament to his unwavering commitment to advancing healthcare and nurturing future leaders in the field.
Dr. Mahendra Sharma
Our 4Es
Efficiency: Key aspects of efficiency in a Shen include streamlined processes, optimized resource allocation, effective project management, and adherence to timelines and budgets.
Expertise: Shen having a skilled and knowledgeable workforce with expertise in various aspects of clinical research, including study design, regulatory compliance, data management, biostatistics, monitoring, and medical writing.
Ethics: Shen adhere to ethical principles and guidelines, such as those outlined in Good Clinical Practice (GCP) guidelines, to ensure the protection of human subjects involved in clinical trials and the integrity of the data collected.
Excellence: Excellence encompasses the commitment to high standards of quality, accuracy, and professionalism in all aspects of our work by committing continuous improvement, quality control measures, ongoing training and development of staff, and a focus on delivering exceptional results to clients and stakeholders.